E.g., 04/20/2018
E.g., 04/20/2018

Labor Day Holiday Shipping Schedule

24 August, 2017

Please be advised the bioMérieux Inc. sites in Durham, NC, St. Louis, MO, Louisville, KY and Lombard, IL will be closed on Monday, September 4, 2017 in observance of the upcoming holiday. 

bioMérieux receives FDA clearance for expanded pathogen identification capability on VITEK® MS

31 July, 2017

With more than 15,000 distinct strains, VITEK® MS provides the microbiology lab with the most comprehensive Mass Spectrometry database to improve clinical decision-making for infectious diseases.

Survivors, Patient Advocates and Clinicians Come to San Diego to Discuss Antimicrobial Stewardship Empowered by Rapid Diagnostics™ 

24 July, 2017

Durham, NC – July 24, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce its 2017 Press Conference at the American Association of Clinical Chemistry: “Antimicrobial Stewardship Empowered by Rapid Diagnostics,” to be held August 2, at 9:00 am (PST) at the San Diego Convention Center. 

bioMérieux – Second-Quarter 2017 Business Review

20 July, 2017

Marcy l'Étoile (France), July 20, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2017.

Product Security Notice

28 June, 2017

The following letter was issued concerning the WannaCry ransomware attack in May 2017. The directions provided to protect your system also apply to the June 2017 Petya ransomware attack.

Independence Day Holiday Shipping Schedule

14 June, 2017

Please be advised the bioMérieux manufacturing and shipping locations in Durham, NC, St. Louis, MO, Louisville, KY and Lombard, IL will be closed on Tuesday, July 4, 2017 in observance of Independence Day.

bioMérieux receives FDA Clearance for BioFire’s FilmArray® Respiratory Panel 2 (RP2)

01 June, 2017

The FilmArray® RP2 reduces sample-to-result time to only 45 minutes while enhancing pathogen coverage and overall sensitivity

bioMérieux supporting the launch of the AMR Industry Alliance

22 May, 2017

Marcy l'Etoile, France, May 2017 - Media Statement - bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to support the launch of the AMR Industry Alliance, a new alliance to drive and measure industry progress to curb antimicrobial resistance.

With New Instrument and Assay Claims, BioMérieux Takes on Antibiotic Stewardship

11 May, 2017

With a recently approved blood culture system, new indications for its procalcitonin (PCT) diagnostic assay, and an arsenal of molecular testing tools, bioMérieux is aiming to become a leader in the increasingly competitive field of antibiotic stewardship.

Sepsis Alliance and bioMérieux, Inc. Expand Partnership for 2017 to Promote Sepsis Awareness and Prevention

10 May, 2017

Durham, NC – San Diego, CA (May 10, 2017) – bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce that its U.S. affiliate, bioMérieux Inc. will be expanding its partnership with Sepsis Alliance. bioMérieux Inc. will serve as the 2017 National Sepsis Awareness and Education Title Sponsor, including sponsorship of Sepsis Alliance’s Sepsis Challenge™ events.

Pioneering Diagnostics